Protext Mobility IncOTC Pink - Current Information:TXTM
- LAST PRICE0.0023
- TODAY'S CHANGE (%)0.0005 (27.7778%)
- Bid / Lots0.0020/ 1,000
- Ask / Lots---/ ---
- Open / Previous Close0.0018 / 0.0018
- Day Range
- 52 Week Range
- Volume5,461,628
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TXTM |
|---|---|---|
| 09:32 ET | 508845 | 0.0018 |
| 10:19 ET | 5000 | 0.0021 |
| 10:21 ET | 35000 | 0.0021 |
| 10:51 ET | 27750 | 0.0018 |
| 11:04 ET | 100000 | 0.0021 |
| 12:32 ET | 9000 | 0.0018 |
| 01:10 ET | 1000000 | 0.0021 |
| 01:12 ET | 250033 | 0.0021 |
| 01:32 ET | 749967 | 0.0021 |
| 02:08 ET | 20033 | 0.0021 |
| 02:22 ET | 200000 | 0.002102 |
| 02:51 ET | 46000 | 0.0021 |
| 03:30 ET | 1500000 | 0.0021 |
| 03:48 ET | 10000 | 0.0021 |
| 03:59 ET | 1000000 | 0.0023 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Protext Mobility Inc | 15.8M | 0.0x | --- |
Curative Biotechnology Inc | 15.8M | -2.7x | --- |
Cardio Diagnostics Holdings Inc | 15.6M | -0.9x | --- |
Vaxxinity Inc | 15.4M | -0.3x | --- |
NeuroBo Pharmaceuticals Inc | 15.0M | -1.2x | --- |
Oncotelic Therapeutics Inc | 16.3M | -2.1x | --- |
Company Information
Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Company’s subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.
Contact Information
- Headquarters
- 1100 Brickell Bay Drive 310747MIAMI, FL, United States 33231
- Phone
- 516-802-0223
- Fax
- 302-655-5049
Executives
- Chief Executive Officer, Director
- Roger Baylis-Duffield
- Director
- David Lewis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.8M |
|---|---|
Revenue (TTM) | $750.00 |
Shares Outstanding | 8.8B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -2.95 |
EPS | $-0.47 |
Book Value | $-3.29 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 21,098.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -131,242.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
